Navigation Links
Maxygen to Host Fourth Quarter and Year End 2007 Financial Results Conference Call on February 12, 2008
Date:1/29/2008

REDWOOD CITY, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company focused on the development of improved protein drugs, will host a conference call to discuss the company's fourth quarter and year end 2007 financial results at 11:30 a.m. ET (8:30 a.m. PT) on Tuesday, February 12, 2008. Russell Howard, Maxygen's chief executive officer, will host the call. A press release announcing Maxygen's fourth quarter and 2007 financial results will be issued that same day at approximately 9:00 a.m. ET.

The call will include discussion of non-GAAP financial measures. Reconciliation of the non-GAAP financial measures to the most directly applicable GAAP measures can be found in the press release announcing Maxygen's fourth quarter and 2007 financial results. This press release will be available February 12, 2008 on Maxygen's website at http://www.maxygen.com/news.php.

Participants in the U.S. can access the call by dialing 866.825.3209 and using the passcode 31366535. International participants can dial 617.213.8061 and use the same passcode. A live webcast of the conference call will be available at http://www.maxygen.com/webcasts.

A telephone replay of the conference call will be available until March 12, 2008. To access the replay, please call 888.286.8010 (U.S.) or 617.801.6888 (international) and use the passcode 60709469. An archived version of the webcast will be available until March 12, 2008 at http://www.maxygen.com/webcasts.

About Maxygen

Maxygen is a biopharmaceutical company focused o
'/>"/>

SOURCE Maxygen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. One-fourth of HIV patients believe their doctors stigmatize them
2. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
3. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
4. Hillenbrand Industries Announces Fourth Quarter 2007 Dividend
5. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
6. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
7. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
8. Health Insurance Premium Growth Slows for Fourth Straight Year
9. Dynatronics Announces Strong Fourth Quarter Profit
10. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
11. BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:New Jersey Orthodontist Patrick T. Cuozzo Launches User-Friendly, State-of-the-Art New Website 2Health News:New Jersey Orthodontist Patrick T. Cuozzo Launches User-Friendly, State-of-the-Art New Website 3Health News:Ask Supermodel Kate Moss... Serious Dangers are Lurking in Nail Salons 2Health News:Ask Supermodel Kate Moss... Serious Dangers are Lurking in Nail Salons 3Health News:Innovative Search Engine for Medical News, Newsguard 2.0, Launched 2Health News:Up-and-Coming Houston Cosmetic Dentist Soon to Mark 5 Years Working with Family at a Family Dental Practice 2Health News:Up-and-Coming Houston Cosmetic Dentist Soon to Mark 5 Years Working with Family at a Family Dental Practice 3Health News:ASPETAR - Qatar Orthopaedic and Sports Medicine Hospital Named FIFA Medical Centre of Excellence 2Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 2Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 3Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 4Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 5Health News:Six in Ten Say Family Put Off Medical Care Due to Cost 6
Breaking Medicine Technology:ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 2Perrigo Confirms Filing for Generic Version of Clobex(R) Spray and Announcement of Lawsuit by Galderma and Dermalogix 3Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 2Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 3Repligen Reports Phase 3 Clinical Trial Results of RG1068 in Pancreatic Imaging 4Michigan Businesses Urged to Study Costs and Affects of U S Healthcare Reform Packages 56786 1Michigan Businesses Urged to Study Costs and Affects of U S Healthcare Reform Packages 56786 2Michigan Businesses Urged to Study Costs and Affects of U S Healthcare Reform Packages 56786 3JHD Group Announces TURNKEY EHR 28TM 29 Service 56783 1JHD Group Announces TURNKEY EHR 28TM 29 Service 56783 2JHD Group Announces TURNKEY EHR 28TM 29 Service 56783 3BioCrossroads Report Defines Strategic Vision for Global Orthopedics Capital 56778 1BioCrossroads Report Defines Strategic Vision for Global Orthopedics Capital 56778 2BioCrossroads Report Defines Strategic Vision for Global Orthopedics Capital 56778 3BioCrossroads Report Defines Strategic Vision for Global Orthopedics Capital 56778 4BioCrossroads Report Defines Strategic Vision for Global Orthopedics Capital 56778 5